Zoetis EVP awarded 1,266 phantom stock units

Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 03/31/2026 - 04:46 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.

Zoetis Inc. Executive Vice President Roxanne Lagano received a grant of 1,266.4405 phantom stock units under the Zoetis Supplemental Savings Plan. Each unit’s value is tied to Zoetis common stock plus a small cash-equivalent component, and units are settled in cash after separation from service.

The grant represents an economic interest equivalent to 426.8022 shares of Zoetis common stock, with a reference value of $38.2000 per phantom stock unit. Following this award, Lagano holds a total of 30,081.5721 phantom stock units, which remain subject to plan transfer and investment rules.

Insider Trade Summary

Grant/Award: 1,266.4405 shares

Grant/Award 1 txn

Insider Lagano Roxanne

Role Executive Vice President

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock Unit	1,266.4405	$38.20	$48K

Holdings After Transaction: Phantom Stock Unit — 30,081.5721 contracts (Direct)

Footnotes (2)

1. F1. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.
2. F2. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

Key Figures

Phantom stock units granted: 1,266.4405 units Reference price per phantom unit: $38.2000 per unit Underlying common stock equivalent: 426.8022 shares +1 more

4 metrics

Phantom stock units granted 1,266.4405 units Award on March 27, 2026

Reference price per phantom unit $38.2000 per unit Grant valuation reference

Underlying common stock equivalent 426.8022 shares Economic exposure linked to grant

Total phantom units after grant 30,081.5721 units Holdings following this transaction

Key Terms

Phantom Stock Unit, Zoetis Supplemental Savings Plan, cash-equivalent investments

3 terms

Phantom Stock Unit financial

"These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash"

Zoetis Supplemental Savings Plan financial

"These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash"

cash-equivalent investments financial

"a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Zoetis (ZTS) executive Roxanne Lagano report on this Form 4?

Roxanne Lagano reported receiving 1,266.4405 phantom stock units as a compensation-related award. These units are issued under the Zoetis Supplemental Savings Plan and provide cash-settled economic exposure to Zoetis common stock, rather than actual shares with voting rights or direct stock ownership.

How are Roxanne Lagano’s Zoetis (ZTS) phantom stock units valued?

Each phantom stock unit’s value is based on Zoetis common stock plus cash-equivalent investments. The units reference a price of $38.2000 and typically include around 5% of value in cash-equivalent investments, so the overall value changes with Zoetis’ market price and those cash-like holdings.

Do the Zoetis (ZTS) phantom stock units give Roxanne Lagano actual shares?

The phantom stock units do not provide actual Zoetis shares; they are cash-settled obligations. Their value is determined by Zoetis common stock performance and cash-equivalent investments, and they are settled in cash after Lagano’s separation from service rather than delivering physical shares.

How many Zoetis (ZTS) phantom stock units does Roxanne Lagano hold after this grant?

After this grant, Roxanne Lagano holds a total of 30,081.5721 phantom stock units. These units represent a deferred, cash-settled economic interest linked to Zoetis common stock and are subject to the Zoetis Supplemental Savings Plan’s rules on transfers and investment fund changes.

What underlying Zoetis (ZTS) common stock exposure is tied to this phantom stock grant?

This award corresponds economically to 426.8022 shares of Zoetis common stock, plus a small cash-equivalent component. The phantom units track the value of those reference shares and cash-equivalent investments but do not confer voting rights or direct share ownership for the reporting executive.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lagano Roxanne

(Last) (First) (Middle)

C/O ZOETIS INC.

10 SYLVAN WAY

(Street)

PARSIPPANY NEW JERSEY 07054

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Zoetis Inc. [ ZTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Vice President

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock Unit(1)	(2)	03/27/2026		A		1,266.4405		(1)	(1)	Common Stock	426.8022	$38.2	30,081.5721	D

Explanation of Responses:

1. These phantom stock units, which were acquired pursuant to the Zoetis Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment fund at any time, provided Zoetis may limit the timing, frequency and permissibility of transfers from one investment fund to another at any time.

2. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock, plus a small amount of cash-equivalent investments (the cash-equivalent investments typically represent around 5% of the total value of the phantom stock unit). Accordingly, the value of each phantom stock unit is determined by reference to the market value of Zoetis common stock and the value of the cash-equivalent investments.

Remarks:

	/s/ Brenda Santuccio, as Attorney-in-Fact	03/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)